We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Hip Surgery Complication Rare But Deadly

By HospiMedica staff writers
Posted on 26 Jan 2007
A new patient safety advisory reports that in rare cases patients undergoing hip replacement surgery experience bone cement implantation syndrome (BCIS). More...


The Pennsylvania Patient Safety Authority (PSA, Harrisburg, USA) has informed that in five out of six reports of BCIS received by the Patient Safety Reporting System (PA-PSRS), the patient died from cardiac arrest associated with implantation of the new hip prosthesis. Elderly patients with underlying heart disease who must receive surgery for a hip fracture using bone cement were found to be most at risk of developing BCIS. Although cardiac arrest and death are the most severe outcomes associated with BCIS, some warning signs that occur within minutes of using the bone cement include: low blood pressure, fluid in the lungs, increased airway resistance, irregular heartbeat, hypothermia, and increased bleeding. The patient safety advisory was published in December 2006.

BCIS occurs when methylmethacrylate (MMA) cement interdigitates within the interstices of cancellous bone. The exothermic binding reaction leads to cement hardening and expansion against prosthetic components. The resultant intramedullary hypertension can cause embolization of fat, bone marrow, cement, and air into the femoral venous channels. The residual monomer can also cause vasodilatation and a decrease in systemic vascular resistance, thought to be the cause for the transient hypotension often seen with cement insertion. The release of tissue thromboplastin may trigger platelet aggregation, microthrombus formation in the lungs, and cardiovascular instability as a result of the circulation of vasoactive substances.

"While bone cement is associated with BCIS, it is important for orthopedic surgeons to know the syndrome is actually caused by the seal and pressure that develops when the hip prosthesis is inserted after the cement has been placed, not by the cement itself,” said Dr. John Clarke, clinical director of PA-PSRS. "Other materials could also cause the same seal and pressure which leads to the syndrome.”

The PSA advisory article includes several risk reduction strategies including evaluating and monitoring the patient's condition before and during surgery for factors indicating high risk, thoroughly cleaning the shaft of the thigh bone before inserting the prosthesis, and using techniques for inserting the cement that minimize the pressure.



Related Links:
Pennsylvania Patient Safety Authority

Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Desk Aneroid Sphyg
Diagnostix 750D+
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.